[Modification of empirical antimicrobial regimen during the first 72 hours of hospitalisation]

E Márquez-Saavedra1, J E Corzo Delgado, S Artacho

  • 1Servicio de Suministros Farmacéuticos, Subdirección de Farmacia y Prestaciones, Servicios Centrales del Servicio Andaluz de Salud, Sevilla, España. emasaavedra@yahoo.es

Insights

Empirical antibiotic therapy prescribed in the Emergency Department (ED) frequently changes during hospitalisation. Microbiological results were seldom used to guide these antibiotic regimen adjustments in pediatric patients.

Area of Science:

  • Infectious Diseases
  • Pediatric Hospital Medicine
  • Antimicrobial Stewardship

Context:

  • Antibiotic therapy is initiated in the Emergency Department (ED) for hospitalized pediatric patients.
  • Early changes to empirical antibiotic regimens are common within the first 72 hours of hospital admission.
  • Understanding these prescribing patterns is crucial for optimizing antimicrobial use.

Purpose:

  • To determine empirical antibiotic therapy in pediatric patients admitted from the ED.
  • To describe antibiotic regimen modifications during the initial 72 hours of hospitalization.
  • To assess the utilization of microbiological data in guiding antibiotic therapy changes.

Summary:

  • A prospective observational study included 225 pediatric patients hospitalized for at least 72 hours after ED admission.
  • Common infections included respiratory, pneumonia, and skin/soft tissue infections.
  • 42% of initial antibiotic regimens were modified, with microbiological results available in only 42% of these cases.

Impact:

  • High frequency of early antibiotic regimen changes suggests potential for de-escalation or optimization.
  • Limited use of microbiological data highlights a gap in evidence-based antimicrobial stewardship.
  • Findings emphasize the need for improved coordination between ED and inpatient teams regarding antibiotic selection and monitoring.
Abstract

Related Concept Videos

Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Antibiotic Selection00:57

Antibiotic Selection

Overview
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...